Biostatistics Center, The George Washington University, Rockville, MD.
Division of Nephrology, University of Washington, Seattle, WA.
Diabetes Care. 2023 Feb 1;46(2):361-368. doi: 10.2337/dc22-1744.
To describe the relationships between the cumulative incidences of long-term complications in individuals with type 1 diabetes (T1D) and assess whether observed associations are independent of age, duration of diabetes, and glycemic levels.
Proliferative diabetic retinopathy (PDR), clinically significant macular edema (CSME), reduced estimated glomerular filtration rate (eGFR), amputations, cardiovascular disease (CVD), and mortality were assessed in the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study over ∼30 years.
The cumulative incidence of complications ranged from 3% (amputations) to 37% (CSME). There were large differences in the cumulative incidence of PDR between participants with versus without prior CSME (66% vs. 15%), reduced eGFR (59% vs. 29%), and amputation (68% vs. 32%); reduced eGFR with or without prior PDR (25% vs. 9%), amputation (48% vs. 13%), and CVD (30% vs. 11%); CVD with or without prior reduced eGFR (37% vs. 14%) and amputation (50% vs. 16%); and mortality with or without prior reduced eGFR (22% vs. 9%), amputation (35% vs. 8%), and CVD (25% vs. 8%). Adjusted for age, duration of T1D, and mean updated HbA1c, the complications and associations with higher risk included PDR with CSME (hazard ratio [HR] 1.88; 95% CI 1.42, 2.50), reduced eGFR (HR 1.41; 95% CI 1.01, 1.97), and CVD (HR 1.43; 95% CI 1.06, 1.92); CSME with higher risk of PDR (HR 3.94; 95% CI 3.18 4.89), reduced eGFR (HR 1.49; 95% CI 1.10, 2.01), and CVD (HR 1.35; 95% CI 1.03, 1.78); reduced eGFR with higher risk of CVD (HR 2.09; 95% CI 1.44, 3.03), and death (HR 3.40; 95% CI 2.35, 4.92); amputation(s) with death (HR 2.97; 95% CI 1.70, 2.90); and CVD with reduced eGFR (HR 1.59; 95% CI 1.08, 2.34) and death (HR 1.95; 95% CI 1.32, 2.90).
Long-term micro- and macrovascular complications and mortality are highly correlated. Age, diabetes duration, and glycemic levels do not completely explain these associations.
描述 1 型糖尿病(T1D)患者长期并发症的累积发生率,并评估观察到的相关性是否独立于年龄、糖尿病病程和血糖水平。
在糖尿病控制和并发症试验/糖尿病干预和并发症流行病学研究中,大约 30 年来评估了增殖性糖尿病视网膜病变(PDR)、临床显著黄斑水肿(CSME)、估算肾小球滤过率(eGFR)降低、截肢、心血管疾病(CVD)和死亡率。
并发症的累积发生率范围为 3%(截肢)至 37%(CSME)。有 CSME 的参与者与无 CSME 的参与者之间 PDR 的累积发生率存在很大差异(66%比 15%)、eGFR 降低(59%比 29%)和截肢(68%比 32%);有或没有先前 PDR 的 eGFR 降低(25%比 9%)、截肢(48%比 13%)和 CVD(30%比 11%);有或没有先前 eGFR 降低的 CVD(37%比 14%)和截肢(50%比 16%);有或没有先前 eGFR 降低的死亡率(22%比 9%)、截肢(35%比 8%)和 CVD(25%比 8%)。调整年龄、T1D 病程和平均更新 HbA1c 后,与更高风险相关的并发症包括 PDR 合并 CSME(风险比[HR]1.88;95%置信区间[CI]1.42,2.50)、eGFR 降低(HR 1.41;95% CI 1.01,1.97)和 CVD(HR 1.43;95% CI 1.06,1.92);CSME 与更高风险的 PDR(HR 3.94;95% CI 3.18 4.89)、eGFR 降低(HR 1.49;95% CI 1.10,2.01)和 CVD(HR 1.35;95% CI 1.03,1.78);eGFR 降低与更高风险的 CVD(HR 2.09;95% CI 1.44,3.03)和死亡(HR 3.40;95% CI 2.35,4.92)相关;截肢与死亡(HR 2.97;95% CI 1.70,2.90)相关;CVD 与 eGFR 降低(HR 1.59;95% CI 1.08,2.34)和死亡(HR 1.95;95% CI 1.32,2.90)相关。
长期的微血管和大血管并发症和死亡率高度相关。年龄、糖尿病病程和血糖水平并不能完全解释这些关联。